Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma convenes its Annual General Meeting 2026
Company announcement – No. 2 / 2026 Zealand Pharma convenes its Annual General Meeting 2026 Copenhagen, Denmark, February 19, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no.
Zealand Pharma Announces Financial Results for the Full Year 2025
Company announcement – No. 1 / 2026 Zealand Pharma Announces Financial Results for the Full Year 2025 2025 marked a quantum leap for Zealand Pharma, with a transformative partnership for petrelintide, strong clinical progress, and…
Sumitomo Pharma shares plunge 12% despite greenlight for Parkinson's treatment
Shares of Japan's Sumitomo Pharma fell over 12%. Japanese government endorsed the company's iPS cell-based therapy for Parkinson's and heart disease. Shares of Japanese drugmaker Sumitomo Pharma fell over 12% Friday on what appeared to be…
Pharma Poised For 10 pc Revenue Growth In FY27
Chennai: The pharmaceutical sector is projected to grow its revenues by 10 per cent in FY27, driven by healthy domestic sales and increased traction in the contract development and manufacturing organisation (CDMO) business. 'Indian pharma is…
The FDA talks over-the-counter freedom. Big Pharma profits from keeping it restricted.
Food and Drug Administration (FDA) Commissioner Marty Makary recently stated that when it comes to drugs that currently require a prescription, 'everything should be over the counter' (OTC) unless they are unsafe or need monitoring. There are…
Vanda Pharma: High Risk, Heavily Discounted - Stock Ahead Of PDUFA This Week (NASDAQ:VNDA)
Vanda Pharmaceuticals reported weak FY25 results, with a GAAP EPS miss and heavy losses, despite 9% revenue growth driven by Fanapt. VNDA's valuation is deeply discounted, trading at 1.4x forward sales and 0.5x EV/sales, reflecting high regulatory…
Big Pharma financially unfazed by White House drug price deals
Big drug companies' pricing deals with the Trump administration barely came up during their most recent round of quarterly earnings calls, in yet another sign that the agreements were mutually beneficial for both parties. Why it matters: The Trump…
Morning Report: Potential Conflict for County Pharma Chief
In October, we revealed the county's top pharmacy official was moonlighting for a New York-based law firm that advises pharmaceutical companies. Now our Lisa Halverstadt reports that full-time Chief Pharmacy Officer Emily Do has dropped the side…
County Pharma Chief's Second Job 'Presented a Potential Conflict of Interest'
A county investigation into its top pharmacy official found that she failed to fully disclose a second gig that presented a potential conflict of interest. Investigators with the county's Office of Ethics and Compliance found that Dr. Emily Do, who…
HC Wainwright Boosts Earnings Estimates for BridgeBio Pharma
BridgeBio's Volatile Week Puts Biotech Stocks Under a Microscope BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) - HC Wainwright boosted their Q2 2026 earnings estimates for shares of BridgeBio Pharma in a research note issued to investors on…
Zealand Pharma A/S (OTCMKTS:ZLDPF) Issues Earnings Results, Beats Expectations By $0.53 EPS
Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.81) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.34) by $0.53, Zacks reports.
Royalty Pharma PLC $RPRX Shares Bought by Aberdeen Group plc
Aberdeen Group plc raised its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 146.2% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 563,225 shares of the biopharmaceutical company's…
Aberdeen Group plc Has $18.83 Million Stock Holdings in NewAmsterdam Pharma Company N.V. $NAMS
Aberdeen Group plc reduced its stake in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 9.9% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund…
Vizag needs more anganwadi centres: East MLA Velagapudi Ramakrishna Babu
Visakhapatnam East MLA Velagapudi Ramakrishna Babu stressed the need to expand and strengthen anganwadi infrastructure in the city. During the Zero-Hour in the Legislative Assembly on Thursday, the MLA urged the State Government to approach the…
Sustained availability of entry-level jobs must be ensured: Accenture CEO Julie Sweet
Citing Accenture's example, she said while the IT bellwether plans to hire more people into entry-level jobs this year than last, the onboarding process will be different, with an eye on advanced AI. “Companies must commit to creating…
Receive a Daily briefing on Pharma Industry News
Get Started